Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.

Wang J, Bardelli M, Espinosa DA, Pedotti M, Ng TS, Bianchi S, Simonelli L, Lim EXY, Foglierini M, Zatta F, Jaconi S, Beltramello M, Cameroni E, Fibriansah G, Shi J, Barca T, Pagani I, Rubio A, Broccoli V, Vicenzi E, Graham V, Pullan S, Dowall S, Hewson R, Jurt S, Zerbe O, Stettler K, Lanzavecchia A, Sallusto F, Cavalli A, Harris E, Lok SM, Varani L, Corti D.

Cell. 2017 Sep 21;171(1):229-241.e15. doi: 10.1016/j.cell.2017.09.002.

2.

Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8384-8389. doi: 10.1073/pnas.1704984114. Epub 2017 Jul 17.

3.

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D.

Science. 2016 Aug 19;353(6301):823-6. doi: 10.1126/science.aaf8505. Epub 2016 Jul 14.

4.

Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes.

Villiger Y, Szanto I, Jaconi S, Blanchet C, Buisson B, Krause KH, Bertrand D, Romand JA.

J Neuroimmunol. 2002 May;126(1-2):86-98.

PMID:
12020960
5.

A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1.

Bánfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, Sinha B, Ligeti E, Demaurex N, Krause KH.

Science. 2000 Jan 7;287(5450):138-42. Erratum in: Science. 2005 Jan 7;307(5706):44.

6.

Decreases in retinol and retinol-binding protein during total parenteral nutrition in rats are not due to a vitamin A deficiency.

Lespine A, Periquet B, Jaconi S, Alexandre MC, Garcia J, Ghisolfi J, Thouvenot JP, Siegenthaler G.

J Lipid Res. 1996 Dec;37(12):2492-501.

7.
8.
9.

Topical retinaldehyde on human skin: biologic effects and tolerance.

Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, Gumowski D, Masouyé I, Salomon D, Siegenthaler G.

J Invest Dermatol. 1994 Dec;103(6):770-4.

10.

Topical glucocorticosteroids modulate the expression of CRABP I and II in human skin differently.

Piletta P, Jaconi S, Siegenthaler G, Didierjean L, Saurat JH.

Exp Dermatol. 1994 Feb;3(1):23-8.

PMID:
8061932
11.

Effect of retinoids on follicular cells.

Bazzano G, Terezakis N, Attia H, Bazzano A, Dover R, Fenton D, Mandir N, Celleno L, Tamburro M, Jaconi S.

J Invest Dermatol. 1993 Jul;101(1 Suppl):138S-142S.

12.

Characterization and expression of a novel human fatty acid-binding protein: the epidermal type (E-FABP).

Siegenthaler G, Hotz R, Chatellard-Gruaz D, Jaconi S, Saurat JH.

Biochem Biophys Res Commun. 1993 Jan 29;190(2):482-7.

PMID:
8427590
13.

Expression of CRABP-I and -II in human epidermal cells. Alteration of relative protein amounts is linked to the state of differentiation.

Siegenthaler G, Tomatis I, Chatellard-Gruaz D, Jaconi S, Eriksson U, Saurat JH.

Biochem J. 1992 Oct 15;287 ( Pt 2):383-9.

14.

Overexpression of cellular retinoic acid-binding protein type II (CRABP-II) and down-regulation of CRABP-I in psoriatic skin.

Siegenthaler G, Tomatis I, Didierjean L, Jaconi S, Saurat JH.

Dermatology. 1992;185(4):251-6.

PMID:
1335801

Supplemental Content

Loading ...
Support Center